tesaglitazar has been researched along with gw 7647 in 1 studies
| Studies (tesaglitazar) | Trials (tesaglitazar) | Recent Studies (post-2010) (tesaglitazar) | Studies (gw 7647) | Trials (gw 7647) | Recent Studies (post-2010) (gw 7647) |
|---|---|---|---|---|---|
| 74 | 13 | 25 | 140 | 0 | 94 |
| Protein | Taxonomy | tesaglitazar (IC50) | gw 7647 (IC50) |
|---|---|---|---|
| Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens (human) | 5 | |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 0.0005 | |
| WD repeat-containing protein 48 | Homo sapiens (human) | 5 | |
| Bile acid receptor | Homo sapiens (human) | 4.91 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, Y; Ishikawa, M; Makishima, M; Noguchi-Yachide, T; Okazaki, S; Shioi, R; Yamaguchi, T | 1 |
1 other study(ies) available for tesaglitazar and gw 7647
| Article | Year |
|---|---|
Switching subtype-selectivity: Fragment replacement strategy affords novel class of peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonists.
Topics: Acetamides; Binding Sites; Genes, Reporter; HEK293 Cells; Humans; Ligands; PPAR alpha; PPAR delta; Protein Binding; Stereoisomerism; Thiazolidinediones | 2017 |